In this study, the species diversity of staphylococci with inducible resistance to macrolides, lincosamides and streptogramin B (MLS B ) isolated from clinical samples, sewage and river water was investigated. Inducible clindamycin resistance was tested using a D-test and macrodilution assays. Inducible cross-resistance (iMLS B phenotype) was examined by PCR of erm gene classes A, B, C, F, G, Q, T and 43. Although ermC was the most frequently detected resistance gene in iMLS B phenotypes of environmental staphylococci (61.2 %), resistance genes encoding iMLS B were more diverse than in staphylococci from hospital samples. In 22.4 % of iMLS B staphylococci from aquatic environments, none of the eight tested erm genes was found. Those isolates and erm43-expressing Staphylococcus lentus displayed low erythromycin MICs (3-16 mg ml ). In contrast to clinical isolates with clearly defined resistance behaviour, resistance patterns against MLS B and MICs for clindamycin of environmental isolates were more diverse. Although the abundance of iMLS B staphylococci in the aquatic environment was lower than in staphylococci from hospital samples, the diversity of resistance genes encoding this phenotype seemed to be higher. Oleandomycin is the best marker to correlate iMLS B phenotype and the respective erm gene. The phenotypical behaviour of environmental isolates may differ from the resistance pattern of clinical iMLS B staphylococci expressing ermA or ermC, and this should be considered for successful treatment of infections.
INTRODUCTION
Macrolides and lincosamides are frequently medicated human and veterinary antibiotics used to treat infections caused by staphylococci (Lina et al., 1999; Lüthje & Schwarz, 2006) . Mechanisms of resistance against these drugs include drug inactivation, export of the antibiotic and ribosomal modification, and result in a variety of phenotypes (Leclercq, 2002) . The last mechanism, leading to combined resistance against macrolides, lincosamides and streptogramin B (MLS B ) in staphylococci, is based on the expression of one or more erm genes of the classes A, B, C, F, G, Q, T, Y, 33 and 43 (Wendlandt et al., 2013) . These genes encode methylases that modify the target site(s) in 23S rRNA and thereby inhibit the binding of MLS B (Wendlandt et al., 2013) . Expression of erm genes can be either inducible or constitutive. Cells with inducible resistance against MLS B are sensitive to these drugs as long as no adequate inducer is present. It is the sequence in front of the respective erm gene that determines which drug is able to act as inducer, and this may serve to distinguish erm genes (Leclercq, 2002) . Cells that constitutively express one erm gene are resistant against all MLS B . Due to deletions, insertions and point mutations, mainly in the region of the translational attenuator, the tertiary structure of the rRNA can be changed leading to accessibility of the start codon. As a result of these changes, the presence of an rRNA-binding inducer is no longer necessary and expression of the erm gene becomes constitutive. The frequency of occurrence and the type of mutation differ depending on the structure of the regulatory leader region as well as on the copy number (Daurel et al., 2008) . The localization of these genes varies: whereas ermA is usually borne by transposon Tn554, ermC is often found on small plasmids (Daurel et al., 2008; Leclercq, 2002) . The transferability of these genetic elements may explain the detection of erm genes in Gram-positive as well as in Gram-negative genera (Leclercq, 2002) . There are many clinical studies examining the abundance of inducible and constitutively expressed MLS B -resistant staphylococci, especially of Staphylococcus aureus with comparable results: 70-80 % of clinical staphylococci are resistant against macrolides, and about 75 % of them reveal ribosomal modifications (Delialioglu et al., 2005; Gul et al., 2008; Witte et al., 2011) . However, the phenomenon of inducible resistance to MLS B is not restricted to staphylococci that have been isolated from human or animal samples. Although the percentage of macrolide-resistant staphylococci in the aquatic environment is lower (20 vs 70-80 % in clinical samples) (Faria et al., 2009; Heß & Gallert, 2014) , 31.1 % of them were revealed to be inducible or have constitutive resistance to clindamycin (Heß & Gallert, 2014) . Whereas clinical isolates with inducible MLS B resistance, which are genetically almost exclusively encoded by ermA or ermC, are phenotypically well characterized (Daurel et al., 2008; Di Modugno et al., 2002; Hamilton-Miller & Shah, 2000) , little is known about 'environmental' iMLS B staphylococci. For successful medication after infection, identification and information about their phenotypic behaviour are necessary. To assess this potential risk for human and animal health, based on the genetic reservoir of staphylococci from an aquatic environment, 49 iMLS B staphylococci were isolated from sewage or from river water and were phenotypically characterized according to their resistance patterns against macrolides. Their reaction to inhibitory concentrations of the lincosamide clindamycin was investigated and compared with a reference group of 19 clinical Staphylococcus isolates.
METHODS
Sampling and strain isolation. During eight sampling campaigns in 2012 and 2013, 24 h composite samples of raw sewage as well as effluents of different treatment steps in the sewage treatment plants in Eriskirch, RV-Langwiese and Merklingen were collected together with river water of Schussen and Argen, two tributaries of Lake Constance in southern Germany. The river water samples were taken downstream of sewage inlet pipes (random samples, five sampling campaigns). Furthermore, water samples were also taken from influents and effluents of the storm water overflow basin in Mariatal and the soil filter in Tettnang (for details concerning sampling locations and the Staphylococcus species diversity in the respective compartments, see Heß & Gallert, 2014; Triebskorn et al., 2013 ; http://www.schussenaktivplus. de). The water samples were taken in 1-litre autoclaved glass bottles and cooled to 4 uC after sampling. For isolation of staphylococci 100 ml samples of undiluted and 10-fold-diluted raw sewage were plated on Chapman-Stone agar dishes containing 0.05 g sodium azide l
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. To obtain isolates, 10-40 ml river water and 25-400 ml sewage treatment plant effluent was filtered through 0.45 mm pore size sterile membrane filters with a diameter of 4.7 cm for concentration. The filters were placed on Chapman-Stone agar and incubated at 37 uC. After 48 h, the colonies were streaked on mannitol salt agar and restreaked once after growth. The clinical staphylococci were obtained from Städtisches Klinikum Karlsruhe and were isolated by the staff of the municipal hospital from samples of different patients, mainly from smears of skin and mucous membranes but also from smears of wounds and blood cultures.
DEV nutrient agar (Roth) were suspended in 0.9 % NaCl solution to an optical density of a McFarland 0.5 standard. Every well of the microtitre plate was inoculated with 100 ml of this suspension. After 24 h of incubation at 37 uC, physiological reactions in the wells of the plates were recorded by photometer analysis. Isolates that could not be identified at the species level with the Micronaut-Staph microtitre plates were identified at the genus level with a Staphylococcus-specific PCR targeting the tuf gene (Martineau et al., 2001 ).
Susceptibility to erythromycin (15 mg; Becton Dickinson), oleandomycin (15 mg; Oxoid Deutschland), clarithromycin (15 mg; Oxoid), azithromycin (15 mg; Oxoid), spiramycin (100 mg; Oxoid), tylosin (30 mg; MAST Diagnostica) and telithromycin (15 mg; Oxoid) was tested by a disc diffusion test according to Deutsche Industrie Norm (2011), and to clindamycin (2 mg) according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI, 2011) . For inoculation, 100 ml of a 100-fold diluted bacterial suspension (McFarland 0.5 standard), prepared from an overnight culture on DEV nutrient agar, was plated on a Mueller-Hinton agar plate. Discs (6 mm) impregnated with the respective antibiotic were placed on the agar plate, and after 18 h of incubation at 37 uC, the zones of inhibition around each antibiotic-containing disc were measured.
Inducible clindamycin resistance was tested by a D-test according to CLSI (2011) with all erythromycin-resistant and clindamycinsusceptible strains. For this purpose, 100 ml of a McFarland 1.0 standard suspension prepared with biomass from an overnight culture on a DEV nutrient agar was streaked onto a Mueller-Hinton agar plate. The 2 mg clindamycin-containing discs were placed 17 mm apart (centre to centre) from the discs impregnated with 15 mg erythromycin. After incubation at 37 uC for 18 h, the bacterial lawn showing flattening of the inhibition zone around the clindamycin discs adjacent to the erythromycin discs indicated the iMLS B phenotype (Fig. 1a) . To verify the result of the D-test, the erythromycininduced clindamycin resistance was tested with a macrodilution assay as described previously (Heß & Gallert, 2014) .
Determination of MIC. For determination of the MICs for erythromycin and clindamycin, colonies from an overnight culture on DEV nutrient agar were suspended in 0.9 % NaCl to the optical density of a McFarland 1.0 standard. One hundred microlitres of the bacterial suspension was streaked onto a Mueller-Hinton agar plate and an Etest strip (bioMérieux), soaked with increasing concentrations of the respective antibiotic (0.016-256 mg ml 21 from one end to urealyticum strain isolated from sewage before (a) and after (b) mutation, showing the 'D-formation' around a 2 mg clindamycincontaining disc adjacent to a disc spotted with 15 mg erythromycin by the 'wild strain' (a) and acquired constitutive resistance against clindamycin by a culture that was pre-grown in the presence of 5 mg clindamycin ml "1 (b).
Clinical and environmental iMLS B -resistant staphylococci the other), was laid on it. After incubation at 37 uC for 18 h, the intercept of bacterial lawn/inhibition zone with the concentration marked on the strip was read.
Detection of erm genes. Inducible clindamycin resistance was examined by testing for the resistance genes ermA, -B, -C, -F, -G, -Q, -T and -43. DNA amplification was performed in a total volume of 25 ml containing 0.625 U True Start HS Taq DNA polymerase, 2.5 mM MgCl 2 (Thermo Fisher Scientific), 0.25 mM each dNTP, 10 mM both primers (double concentration for the detection of erm43) and 0.5 ml template DNA that was extracted with phenol/ chloroform. Used primer sequences and PCR protocols have been described previously (Feßler et al., 2010; Koike et al., 2010; Schwendener & Perreten, 2012) . Successful DNA extraction of all strains that tested negative for the eight erm genes was checked by PCR amplification of a tuf gene fragment specific for the genus Staphylococcus (Martineau et al., 2001) . The PCR products were separated on a 2 % agarose gel strained with ethidium bromide to identify the respective amplicons.
Mutation experiments. To test the reaction of the 68 D-test-positive (iMLS B ) Staphylococcus isolates against inhibitory concentrations of clindamycin in the absence of an inducer, growth on clindamycin screening plates was checked. For this purpose, 10 ml bacterial suspension, prepared with biomass from an overnight culture on DEV nutrient agar (10 ml McFarland 0.5 standard5~10 6 cells) of the respective strain was dropped on a Mueller-Hinton agar without antibiotic (non-inhibited growth control; Fig. 2a ) and on plates with 1, 2 (Fig. 2b) , 5 and 10 mg clindamycin ml
. All plates were incubated at 37 uC for up to 48 h. Colonies grown on the clindamycin screening plates (from one to many, depending on the mutation rate) were streaked on a Mueller-Hinton agar plate containing 5 mg clindamycin ml 21 in order to obtain biomass for MIC determination with Etest strips. If their MIC in the clindamycin Etest was now ¢256 mg ml 21 , these strains were considered to be mutated and were used as the inoculum for another D-test (e.g. Fig. 1b) . No inhibition zone was visible around the disc containing 2 mg clindamycin).
Strains that were originally 'resistant' against ,0.75 mg clindamycin ml 21 (classified as non-resistant) but did grow in the presence of 1 and 2 mg clindamycin ml 21 on the screening plate were transferred onto a Mueller-Hinton agar plate that contained 5 mg clindamycin ml
. If they did not grow, they were considered to be adapted (more resistant to clindamycin than the original 'wild strains'). Their MIC against clindamycin was checked with clindamycin Etest strips. In order to determine the frequency of mutation, the number of colonies grown was correlated with the number of cells dropped on the plate.
RESULTS

Species diversity and abundance of erm genes
Thirteen of the 19 clinical Staphylococcus isolates with the iMLS B phenotype belonged to S. aureus, the most prominent species causing human infections. All environmental isolates were coagulase-negative staphylococci (CNS) belonging to seven identified species and seven non-identified Staphylococcus sp. (Table 1 ). Whereas Staphylococcus epidermidis was obtained from human samples as well as from water samples, Staphylococcus hominis with inducible MLS B resistance was not isolated from aquatic samples. In general, the species diversity showing cross-resistance to MLS B compounds was higher in sewage and in river water than in hospital samples. This may be due to the fact that only 'special' CNS, isolated from human specimens, were obtained from the hospital. Remarkably, no S. aureus was isolated from aquatic samples (Table 1) . In our study, 69.2 % of the clinical S. aureus isolates with inducible cross-resistance carried the ermA gene and 30.8 % carried the ermC gene. The predominant detected erm gene in clinical CNS (100 %) and environmental CNS (61.2 %) was ermC (Table 1) . ermA could only be detected in two of the 49 (4.1 %) environmental CNS. The inducible resistance to MLS B of all Staphylococcus lentus strains, isolated from sewage and river water, was genetically determined by erm43. Eleven of 49 environmental stains (22.4 %) with the iMLS B phenotype were negative for the erm gene classes A, B, C, F, G, Q, T and 43 (Table 1) .
Phenotypical characterization of clinical and environmental iMLS B staphylococci with respective erm genes Expression of different erm genes results in distinguishable patterns of phenotypical resistance to macrolides (Table 2) . In contrast to ermA-encoded inducible MLS B resistance in staphylococci, ermC-encoded cross-resistance leads to high-level resistances against oleandomycin and clarithromycin. This was clearly visible in the agar diffusion test, which displayed no inhibition zones at all (Table 2) . In comparison to clarithromycin, oleandomycin seemed to be a better marker for distinguishing between ermA and ermC because of higher differences in the inhibition zones, especially for clinical isolates (Table 2) . Using oleandomycin as a marker for expression of inducible resistance against MLS B antibiotics was also possible for environmental staphylococci with the iMLS B phenotype. Nevertheless, it is important to consider that their behaviour against this antibiotic was not always as clear as that described for clinical isolates: 63.3 % of environmental ermC-positive staphylococci displayed small inhibition zones around the disc (data not shown). . One strain had a very high mutation frequency with confluent growth after 48 h incubation. Single colonies were seen earlier. In another 'drop inoculation', two mutations can be seen, whereas in each of five inoculation spots one mutation occurs.
One possibility for distinguishing between ermA-and ermC-encoded inducible MLS B cross-resistance, which is significant for clinical as well as for environmental isolates, was the determination of the MIC against erythromycin. In the Etest, ermC-positive staphylococci displayed no inhibition zone along the strip (MIC ¢256 mg ml 21 ). Isolates with ermA-encoded resistance also had a similarly high MIC for erythromycin (Table 2) , but in contrast to ermC, ermA was expressed heterologously, which was observable by single colonies growing in the inhibition ellipse (Fig. 3) . The MIC of erythromycin of erm43-possessing S. lentus varied between 3 and 16 mg ml 21 (Table 2) , and no heterologous expression could be detected. Except for two staphylococci stains with an iMLS B phenotype not encoded by ermA, -B, -C, -F, -G, -Q, -T or -43, all displayed similar low erythromycin MICs in the above-mentioned range (data not shown).
The MICs against clindamycin of clinical ermA-positive staphylococci were about 0.1 mg ml
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; those of the two environmental staphylococci with the above-mentioned resistance gene were 0.2 and 0.4 mg ml
. The same phenomenon could be detected for isolates with an iMLS B phenotype encoded by ermC: the MICs of the clinical staphylococci were in the range of 0.06-0.2 mg ml 21 except for one strain of S. hominis with an MIC for clindamycin of 0.38 mg ml
. The MICs of the environmental isolates revealed a higher variability in the range of 0.02-0.625 mg ml
. Six of the 30 environmental ermC-positive CNS had an MIC below 0.06 mg ml 21 (20 %) and five of the 30 environmental ermC-positive CNS had an MIC higher than 0.2 mg ml 21 (16.7 %). The differences in the MIC of clindamycin could not be associated with a certain species of staphylococci. Our erm43-positive S. lentus isolates showed MICs for clindamycin in the range of 0.06-0.5 mg ml 21 and those of the environmental iMLS B CNS without ermA, -B, -C, -F, -G, -T, -Q or -43 displayed MICs between 0.02 and 0.75 mg ml
. Therefore, it seemed that the described phenomenon of a wide range of MICs for clindamycin was characteristic of environmental strains, as those of the clinical isolates were within a much smaller concentration range. Drawing conclusions about the coding class of erm genes on the basis of the diameters of the inhibition zones around discs that contained tylosin and spiramycin was not possible for the clinical or environmental isolates. The diameter of the inhibition zone around the oleandomycin-containing disc was the best marker to assign an iMLS B Staphylococcus isolate to the expression of the respective erm gene based on phenotypical observations, independent of its origin.
Reaction of staphylococci to inhibitory clindamycin concentrations
In order to test whether differences concerning the reaction to inhibitory concentrations of clindamycin between clinical and environmental iMLS B staphylococci exist, growth of the respective strains on Mueller-Hinton agar in the presence of different concentrations of the antibiotic was checked. Forty per cent of the clinical and environmental strains of Table 1 . Abundance of erm genes at the species level for staphylococci from clinical and environmental sources and reaction to inhibitory clindamycin concentrations erm? indicates that none of the respective erm gene classes (A, B, C, F, G, Q, T or 43) gave a positive PCR product. n, Number of isolates; n-m: number of mutated isolates (inducible resistant strains that became constitutively resistant after incubation with inhibitory concentrations of clindamycin); n-a: number of adapted isolates (inducible resistant strains that remained inducible resistant but became less susceptible against clindamycin).
Staphylococcus species ermA ermC erm43 erm? n n -m n-a n n -m n-a n n -m n-a n n -m n-a staphylococci, 50 % of the S. aureus isolates and 33.3 % of the CNS that expressed the ermC gene mutated (changed their behaviour from inducible to constitutive resistance against clindamycin) on screening plates in the presence of different inhibitory concentrations of clindamycin (Table 1 and Fig. 2 ). The frequencies of mutation of clinical and environmental isolates were in the same order (about 1610 26 ), independent of the species and the origin of the strain (Table 3) . None of our two environmental ermApositive CNS or the six S. lentus strains carrying the erm43 gene mutated and only one of the nine clinical ermApositive S. aureus strains (11.1 %) changed its susceptibility to clindamycin during the experiment. There was no correlation between mutation frequency and the clindamycin concentration on the screening plate with respect to the species and between clinical and environmental isolates (Table 3) . Two isolates, one ermA-expressing S. aureus and one ermC-expressing S. cohnii ssp. urealyticum, showed clearly higher mutation rates (.2.5610
Human isolates
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; Table 3 ).
Three of the six erm43-positive S. lentus strains (50 %) adapted and grew on the 1 mg clindamycin ml 21 screening plate. Growth on Mueller-Hinton agar plates with this antibiotic concentration also occurred for four environmental Staphylococcus isolates (36.4 %) whose iMLS B phenotype was not encoded by ermA, -B, -C, -F, -G, -Q, -T or -43 (Table 1) .
DISCUSSION
In clinical CNS, ermC is the predominant detected erm gene (Gherardi et al., 2009; Gul et al., 2008; Lina et al., 1999) . Coinciding with this finding, inducible MLS B resistance of our environmental CNS was also abundantly encoded by ermC (61.2 %). Possibly, the widespread distribution of this gene in different species of staphylococci in the aquatic environment can be explained by its insertion into small MICs between 0.06 and 0.5 mg ml plasmids, usually in the range of 2.3-4.4 kb (Wendlandt et al., 2013) . In contrast, the ermA gene, which was integrated into transposons Tn554 and Tn917/Tn551 and present in a single copy or only a few copies in the chromosome, was detected less frequently in the aquatic environment (4.1 %) (Daurel et al., 2008; Wendlandt et al., 2013) . The different abundance of these mobile determinants in the aquatic environment could be explained by different transfer rates. Unfortunately, to our knowledge, there are no data describing terms for horizontal erm gene transfer with focus on the different classes and the respective transfer rates in the aquatic ecosystem. To date, the erm43 gene has only been reported for S. lentus and detected in strains isolated from humans, dogs and chickens (Schwendener & Perreten, 2012) . In this study, the erm43 gene was detected in S. lentus strains isolated from the aquatic environment for the first time, to the best of our knowledge. Whereas inducible clindamycin resistance of clinical staphylococci by expression of the ermA or ermC gene has been detected almost universally (Gherardi et al., 2009; Gul et al., 2008; Lina et al., 1999) in staphylococci isolated from aquatic environments, the diversity of erm genes was higher than in strains isolated in hospitals. Unfortunately, investigations of the distribution of erm genes in Staphylococcus isolates from environmental sources are very rare. Koike et al. (2010) examined waste lagoons and subsurface waters from swine farms on the basis of MLS B methylases for molecular ecology. They reported a high diversity of erm genes, but, due to their molecular approach and the wide distribution of the recently detected approximately 40 resistance genes of the erm gene family (Leclercq, 2002) among Gram-positive as well as among Gram-negative bacteria, it was not possible to assign them to species of the genus Staphylococcus.
Phenotypic resistance patterns of ermA-or ermC-carrying staphylococci from hospital samples have already been described (Daurel et al., 2008; Di Modugno et al., 2002) . The heterologously expressed erythromycin resistance of our ermA-positive environmental staphylococci was also observed by Di Modugno et al. (2002) during MIC determinations. Di Modugno et al. (2002) distinguished between the two end points, 'changing from confluent to light growth' and 'changing from light growth to no growth'. As a possible explanation for this phenomenon, they discussed that, whereas ermC leads to dimethylation of a specific residue in 23S rRNA, other genetic determinants may cause monomethylation at the same position. To date, such low erythromycin MICs as in environmental erm43-expressing S. lentus strains and in nine Staphylococcus strains with an iMLS B phenotype, which were not encoded by ermA, -B, -C, -F, -G, -Q, -T or -43 (3-16 mg ml
21
), are associated with other resistance mechanisms like efflux pumps, which are encoded for instance by msrA (Hauschild & Schwarz, 2010) . Our phenotypic investigations showed that, on the basis of low-level erythromycin resistance, it was not possible to exclude inducible resistance to MLS B antibiotics and, as a consequence, rather low MICs to erythromycin were not a sufficient criterion to decide whether clindamycin could be used to treat an infection caused by such Staphylococcus strains. In accordance with our observations, concerning the clindamycin MICs of clinical isolates, Le Bouter et al. has not yet been reported for iMLS B staphylococci, nor for ) in contrast to their ermC-encoded resistance (mean MIC 3 mg ml 21 ), our ermA-expressing isolates did not reveal significantly larger inhibition zones compared with those that expressed the ermC gene (Table 2 ).
The mutation frequencies of our environmental ermCexpressing CNS (Table 3) were higher than those reported for ermC-expressing S. aureus, which ranged between 1.7610 26 and 4.4610
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. The findings of Daurel et al. (2008) , which indicated that their ermA-expressing S. aureus mutated 14 times less than ermC-possessing S. aureus, support our observation that no correlation exists between species and their mutation frequency. The frequency seems to be dependent on the encoding erm gene, especially on the respective structures of the attenuator region. Whereas the attenuator region of ermC comprises only one encoded leader peptide and four inverted repeats, the respective region of ermA is longer and more complex, and includes sequences encoding two leader peptides and six inverted repeats (Daurel et al., 2008) . The similarity to the attenuator region of the erm43 gene, which also comprises sequences encoding two leader peptides (Schwendener & Perreten, 2012) , might be a possible explanation for our result that none of the six S. lentus isolates that expressed the erm43 gene mutated during incubation with inhibitory clindamycin concentrations. Possibly, the clearly higher mutation rates of the two isolates of this study, as well as the fluctuations determined for strains belonging to the same species and possessing the same erm gene [as, for example, reported by Daurel et al. (2008) ], could be explained on the basis of sequence analysis.
To conclude, the abundance of staphylococci with inducible cross-resistance to MLS B antibiotics that were isolated from the aquatic environment was lower than that isolated from hospital samples. The diversity of resistance genes encoding the mechanism of ribosomal modification and their phenotypic expressions seemed to be much more variable. Whereas environmental Staphylococcus strains with inducible MLS B resistance, encoded by ermA or ermC, showed phenotypic resistance patterns and reactions to inhibitory concentrations of clindamycin assignable to the respective resistance gene, isolates from sewage and river water that harboured the erm43 gene, or so far undetected resistance genes, did not behave as expected for this resistance mechanism. Collectively, environmental iMLS B CNS displayed a broader range of reactions against the different MLS B compounds, possibly as a result of adaptation to the permanently changing conditions in their ecosystem. For successful treatment of infections caused by such strains, it is important to know their phenotypic characteristics for identification and medication with a suitable antibiotic.
